Current status of preoperative endoscopic biliary drainage for distal and hilar biliary obstruction.
biliary drainage
cholangiocarcinoma
endoscopic biliary drainage
endoscopic biliary stenting
pancreatic cancer
Journal
Digestive endoscopy : official journal of the Japan Gastroenterological Endoscopy Society
ISSN: 1443-1661
Titre abrégé: Dig Endosc
Pays: Australia
ID NLM: 9101419
Informations de publication
Date de publication:
17 Apr 2024
17 Apr 2024
Historique:
received:
29
09
2023
accepted:
18
02
2024
medline:
17
4
2024
pubmed:
17
4
2024
entrez:
17
4
2024
Statut:
aheadofprint
Résumé
The purpose of preoperative biliary drainage (PBD) is to reduce complications during the perioperative period. The extrahepatic bile duct comprises distal and hilar bile ducts and assessing the need for PBD must be considered separately for each duct, as surgical procedures and morbidities vary. The representative disease-causing distal bile duct obstruction is pancreatic cancer. A randomized controlled trial has revealed that PBD carries the risk of recurrent cholangitis and pancreatitis before surgery, thus eliminating the need for PBD when early surgery is feasible. However, neoadjuvant therapy has seen a rise in recent years, resulting in longer preoperative waiting periods and an increased demand for PBD. In such cases, metal stents are preferable to plastic stents due to their lower stent occlusion rates. When endoscopic transpapillary biliary drainage (EBD) is not viable, endoscopic ultrasound-guided biliary drainage may be a suitable substitute. In the hilar bile duct, the representative disease-causing obstruction is hilar cholangiocarcinoma. PBD's necessity has long been a subject of contention. In spite of earlier criticisms of routine PBD, recent views have emerged recommending PBD, particularly when major hepatectomy is required, to prevent postoperative liver failure. Given the risk of tumor seeding associated with percutaneous transhepatic biliary drainage, EBD is preferable. Nevertheless, as its shortcomings involve recurrent cholangitis until surgery due to stent or tube obstruction, it is necessary to seek out novel approaches to circumvent complications. In this review we summarize the current evidence for PBD in patients with distal and hilar biliary obstruction.
Types de publication
Journal Article
Review
Langues
eng
Sous-ensembles de citation
IM
Informations de copyright
© 2024 Japan Gastroenterological Endoscopy Society.
Références
Global Burden of Disease 2019 Cancer Collaboration, Kocarnik JM, Compton K et al. Cancer incidence, mortality, years of life lost, years lived with disability, and disability‐adjusted life years for 29 cancer groups from 2010 to 2019: A systemic analysis for the Global Burden of Disease Study 2019. JAMA Oncol 2022; 8: 420–444.
Rawla P, Sunkara T, Gaduputi V. Epidemiology of pancreatic cancer: Global trends, etiology and risk factors. World J Oncol 2019; 10: 10–27.
Sharma A, Sharma KL, Gupta A, Yadav A, Kumar A. Gallbladder cancer epidemiology, pathogenesis and molecular genetics: Recent update. World J Gastroenterol 2017; 23: 3978–3998.
Miranda‐Filho A, Piñeros M, Ferreccio C et al. Gallbladder and extrahepatic bile duct cancers in the Americas: Incidence and mortality patterns and trends. Int J Cancer 2020; 147: 978–989.
Bridgewater JA, Goodman KA, Kalyan A, Mulcahy MF. Biliary tract cancer: Epidemiology, radiotherapy, and molecular profiling. Am Soc Clin Oncol Educ Book 2016; 35: e194–e203.
Mueller M, Breuer E, Mizuno T et al. Perihilar cholangiocarcinoma – novel benchmark values for surgical and oncological outcomes from 24 expert centers. Ann Surg 2021; 274: 780–788.
Palanivelu C, Senthilnathan P, Sabnis SC et al. Randomized clinical trial of laparoscopic versus open pancreatoduodenectomy for periampullary tumours. Br J Surg 2017; 104: 1443–1450.
Poves I, Burdío F, Morató O et al. Comparison of perioperative outcomes between laparoscopic and open approach for pancreatoduodenectomy: The PADULAP randomized controlled trial. Ann Surg 2018; 268: 731–739.
van Hilst J, de Rooij T, Bosscha K et al. Laparoscopic versus open pancreatoduodenectomy for pancreatic or periampullary tumours (LEOPARD‐2): A multicentre, patient‐blinded, randomised controlled phase 2/3 trial. Lancet Gastroenterol Hepatol 2019; 4: 199–207.
Dindo D, Demartines N, Clavien PA. Classification of surgical complications: A new proposal with evaluation in a cohort of 6336 patients and results of a survey. Ann Surg 2004; 240: 205–213.
Rahbari NN, Garden OJ, Padbury R et al. Post‐hepatectomy haemorrhage: A definition and grading by the International Study Group of Liver Surgery (ISGLS). HPB (Oxford) 2011; 13: 528–535.
Nagino M, Hirano S, Yoshitomi H et al. Clinical practice guidelines for the management of biliary tract cancers 2019: The 3rd English edition. J Hepatobiliary Pancreat Sci 2021; 28: 26–54.
Okusaka T, Nakamura M, Yoshida M et al. Clinical practice guidelines for pancreatic cancer 2022 from the Japan Pancreas Society: A synopsis. Int J Clin Oncol 2023; 28: 493–511.
Dumonceau JM, Tringali A, Papanikolaou IS et al. Endoscopic biliary stenting: Indications, choice of stents, and results: European Society of Gastrointestinal Endoscopy (ESGE) clinical guideline – updated October 2017. Endoscopy 2018; 50: 910–930.
Qumseya BJ, Jamil LH, Elmunzer BJ et al. ASGE guideline on the role of endoscopy in the management of malignant hilar obstruction. Gastrointest Endosc 2021; 94: 222–234.e22.
Hameed A, Pang T, Chiou J et al. Percutaneous vs. endoscopic pre‐operative biliary drainage in hilar cholangiocarcinoma – a systematic review and meta‐analysis. HPB (Oxford) 2016; 18: 400–410.
Arakura N, Takayama M, Ozaki Y et al. Efficacy of preoperative endoscopic nasobiliary drainage for hilar cholangiocarcinoma. J Hepato‐Biliary‐Pancreat Surg 2009; 16: 473–477.
Kawashima H, Itoh A, Ohno E et al. Preoperative endoscopic nasobiliary drainage in 164 consecutive patients with suspected perihilar cholangiocarcinoma: A retrospective study of efficacy and risk factors related to complications. Ann Surg 2013; 257: 121–127.
Kawakami H, Kuwatani M, Onodera M et al. Endoscopic nasobiliary drainage is the most suitable preoperative biliary drainage method in the management of patients with hilar cholangiocarcinoma. J Gastroenterol 2011; 46: 242–248.
Hirano S, Tanaka E, Tsuchikawa T et al. Oncological benefit of preoperative endoscopic biliary drainage in patients with hilar cholangiocarcinoma. J Hepatobiliary Pancreat Sci 2014; 21: 533–540.
Jo JH, Chung MJ, Han DH et al. Best options for preoperative biliary drainage in patients with Klatskin tumors. Surg Endosc 2017; 31: 422–429.
Maeda T, Ebata T, Yokoyama Y et al. Preoperative course of patients undergoing endoscopic nasobiliary drainage during the management of resectable perihilar cholangiocarcinoma. J Hepatobiliary Pancreat Sci 2019; 26: 341–347.
Miura S, Kanno A, Masamune A et al. Bismuth classification is associated with the requirement for multiple biliary drainage in preoperative patients with malignant perihilar biliary stricture. Surg Endosc 2015; 29: 1862–1870.
Nimura Y. Preoperative biliary drainage before resection for cholangiocarcinoma (Pro). HPB (Oxford) 2008; 10: 130–133.
Kawashima H, Ohno E, Ishikawa T et al. Endoscopic management of perihilar cholangiocarcinoma. Dig Endosc 2022; 34: 1147–1156.
Ducreux M, Cuhna AS, Caramella C et al. Cancer of the pancreas: ESMO clinical practice guidelines for diagnosis, treatment and follow‐up. Ann Oncol 2015; 26 (Suppl 5): v56–v68.
Khorana AA, Mangu PB, Berlin J et al. Potentially curable pancreatic cancer: American Society of Clinical Oncology clinical practice guideline. J Clin Oncol 2016; 34: 2541–2556.
Vogel A, Bridgewater J, Edeline J et al. Biliary tract cancer: ESMO clinical practice guideline for diagnosis, treatment and follow‐up. Ann Oncol 2023; 34: 127–140.
Van der Gaag NA, Rauws EAJ, van Eijck CHJ et al. Preoperative biliary drainage for cancer of the head of the pancreas. N Engl J Med 2010; 362: 129–137.
Tol JA, van Hooft JE, Timmer R et al. Metal or plastic stents for preoperative biliary drainage in resectable pancreatic cancer. Gut 2016; 65: 1981–1987.
Song TJ, Lee JH, Lee SS et al. Metal versus plastic stents for drainage of malignant biliary obstruction before primary surgical resection. Gastrointest Endosc 2016; 84: 814–821.
Mandai K, Tsuchiya T, Kawakami H et al. Fully covered metal stents vs plastic stents for preoperative biliary drainage in patients with resectable pancreatic cancer without neoadjuvant chemotherapy: A multicenter, prospective, randomized controlled trial. J Hepatobiliary Pancreat Sci 2022; 29: 1185–1194.
Gardner TB, Spangler CC, Byanova KL et al. Cost‐effectiveness and clinical efficacy of biliary stents in patients undergoing neoadjuvant therapy for pancreatic adenocarcinoma in a randomized controlled trial. Gastrointest Endosc 2016; 84: 460–466.
Seo DW, Sherman S, Dua KS et al. Covered and uncovered biliary metal stents provide similar relief of biliary obstruction during neoadjuvant therapy in pancreatic cancer: A randomized trial. Gastrointest Endosc 2019; 90: 602–612.e4.
Tamura T, Itonaga M, Ashida R et al. Covered self‐expandable metal stents versus plastic stents for preoperative biliary drainage in patient receiving neo‐adjuvant chemotherapy for borderline resectable pancreatic cancer: Prospective randomized study. Dig Endosc 2021; 33: 1170–1178.
Eshuis WJ, van der Gaag NA, Rauws EAJ et al. Therapeutic delay and survival after surgery for cancer of the pancreatic head with or without preoperative biliary drainage. Ann Surg 2010; 252: 840–849.
Cavell LK, Allen PJ, Vinoya C et al. Biliary self‐expandable metal stents do not adversely affect pancreaticoduodenectomy. Am J Gastroenterol 2013; 108: 1168–1173.
Coté GA, Kumar N, Ansstas M et al. Risk of post‐ERCP pancreatitis with placement of self‐expandable metallic stents. Gastrointest Endosc 2010; 72: 748–754.
Harai S, Hijioka S, Nagashio Y et al. Comparison of 6‐mm and 10‐mm‐diameter, fully‐covered, self‐expandable metallic stents for distal malignant biliary obstruction. Endosc Int Open 2023; 11: E340–E348.
Motoi F, Kosuge T, Ueno H et al. Randomized phase II/III trial of neoadjuvant chemotherapy with gemcitabine and S‐1 versus upfront surgery for resectable pancreatic cancer (Prep‐02/JSAP05). Jpn J Clin Oncol 2019; 49: 190–194.
Mokdad AA, Minter RM, Zhu H et al. Neoadjuvant therapy followed by resection versus upfront resection for resectable pancreatic cancer: A propensity score matched analysis. J Clin Oncol 2017; 35: 515–522.
Artifon ELA, Aparicio D, Paione JB et al. Biliary drainage in patients with unresectable, malignant obstruction where ERCP fails: Endoscopic ultrasonography‐guided choledochoduodenostomy versus percutaneous drainage. J Clin Gastroenterol 2012; 46: 768–774.
Lee TH, Choi JH, Park DH et al. Similar efficacies of endoscopic ultrasound‐guided transmural and percutaneous drainage for malignant distal biliary obstruction. Clin Gastroenterol Hepatol 2016; 14: 1011–1019.e3.
Sharaiha RZ, Khan MA, Kamal F et al. Efficacy and safety of EUS‐guided biliary drainage in comparison with percutaneous biliary drainage when ERCP fails: A systematic review and meta‐analysis. Gastrointest Endosc 2017; 85: 904–914.
Janet J, Albouys J, Napoleon B et al. Pancreatoduodenectomy following preoperative biliary drainage using endoscopic ultrasound‐guided choledochoduodenostomy versus a transpapillary stent: A multicenter comparative cohort study of the ACHBT‐French‐SFED intergroup. Ann Surg Oncol 2023; 30: 5036–5046.
Mukai S, Itoi T, Tsuchiya T et al. Clinical feasibility of endoscopic ultrasound‐guided biliary drainage for preoperative management of malignant biliary obstruction (with videos). J Hepatobiliary Pancreat Sci 2023; 30: 983–992.
Mehrabi A, Khajeh E, Ghamarnejad O et al. Meta‐analysis of the efficacy of preoperative biliary drainage in patients undergoing liver resection for perihilar cholangiocarcinoma. Eur J Radiol 2020; 125: 108897.
Celotti A, Solaini L, Montori G, Coccolini F, Tognali D, Baiocchi G. Preoperative biliary drainage in hilar cholangiocarcinoma: Systematic review and meta‐analysis. Eur J Surg Oncol 2017; 43: 1628–1635.
Yan K, Tian J, Xu J et al. The value of preoperative biliary drainage in hilar cholangiocarcinoma: A systematic review and meta‐analysis of 10 years' literatures. Int J Clin Exp Med 2018; 11: 3462–3472.
Teng F, Tang YY, Dai JL, Li Y, Chen ZY. The effect and safety of preoperative biliary drainage in patients with hilar cholangiocarcinoma: An updated meta‐analysis. World J Surg Oncol 2020; 18: 174.
Franken LC, Schreuder AM, Roos E et al. Morbidity and mortality after major liver resection in patients with perihilar cholangiocarcinoma: A systematic review and meta‐analysis. Surgery 2019; 165: 918–928.
Noie T, Sugawara Y, Imamura H, Takayama T, Makuuchi M. Selective versus total drainage for biliary obstruction in the hepatic hilus: An experimental study. Surgery 2001; 130: 74–81.
Ishizawa T, Hasegawa K, Sano K, Imamura H, Kokudo N, Makuuchi M. Selective versus total biliary drainage for obstructive jaundice caused by a hepatobiliary malignancy. Am J Surg 2007; 193: 149–154.
Nagino M, Ebata T, Yokoyama Y et al. Evolution of surgical treatment for perihilar cholangiocarcinoma: A single‐center 34‐year review of 574 consecutive resections. Ann Surg 2013; 258: 129–140.
Seyama Y, Kubota K, Sano K et al. Long‐term outcome of extended hemihepatectomy for hilar bile duct cancer with no mortality and high survival rate. Ann Surg 2003; 238: 73–83.
Sano T, Shimada K, Sakamoto Y, Yamamoto J, Yamasaki S, Kosuge T. One hundred two consecutive hepatobiliary resections for perihilar cholangiocarcinoma with zero mortality. Ann Surg 2006; 244: 240–247.
Wakai T, Shirai Y, Sakata J et al. Clinicopathological features of benign biliary strictures masquerading as biliary malignancy. Am Surg 2012; 78: 1388–1391.
Roos E, Hubers LM, Coelen RJS et al. IgG4‐associated cholangitis in patients resected for presumed perihilar cholangiocarcinoma: A 30‐year tertiary care experience. Am J Gastroenterol 2018; 113: 765–772.
Nakai Y, Yamamoto R, Matsuyama M et al. Multicenter study of endoscopic preoperative biliary drainage for malignant hilar biliary obstruction: E‐POD hilar study. J Gastroenterol Hepatol 2018; 33: 1146–1153.
Kennedy TJ, Yopp A, Qin Y et al. Role of preoperative biliary drainage of liver remnant prior to extended liver resection for hilar cholangiocarcinoma. HPB (Oxford) 2009; 11: 445–451.
Wiggers JK, Groot Koerkamp B, Cieslak KP et al. Postoperative mortality after liver resection for perihilar cholangiocarcinoma: Development of a risk score and importance of biliary drainage of the future liver remnant. J Am Coll Surg 2016; 223: 321–331.e1.
Chen GF, Yu WD, Wang JR, Qi FZ, Qiu YD. The methods of preoperative biliary drainage for resectable hilar cholangiocarcinoma patients: A protocol for systematic review and meta analysis. Medicine 2020; 99: e20237.
Tang Z, Yang Y, Meng W, Li X. Best option for preoperative biliary drainage in Klatskin tumor: A systematic review and meta‐analysis. Medicine 2017; 96: e8372.
Al Mahjoub AA, Menahem B, Fohlen A et al. Preoperative biliary drainage in patients with resectable perihilar cholangiocarcinoma: Is percutaneous transhepatic biliary drainage safer and more effective than endoscopic biliary drainage? A meta‐analysis. J Vasc Interv Radiol 2017; 28: 576–582.
Coelen RJS, Roos E, Wiggers JK et al. Endoscopic versus percutaneous biliary drainage in patients with resectable perihilar cholangiocarcinoma: A multicentre, randomised controlled trial. Lancet Gastroenterol Hepatol 2018; 3: 681–690.
Takahashi Y, Nagino M, Nishio H, Ebata T, Igami T, Nimura Y. Percutaneous transhepatic biliary drainage catheter tract recurrence in cholangiocarcinoma. Br J Surg 2010; 97: 1860–1866.
Komaya K, Ebata T, Fukami Y et al. Percutaneous biliary drainage is oncologically inferior to endoscopic drainage: A propensity score matching analysis in resectable distal cholangiocarcinoma. J Gastroenterol 2016; 51: 608–619.
Ishiwatari H, Kawabata T, Kawashima H et al. Endoscopic nasobiliary drainage versus endoscopic biliary stenting for preoperative biliary drainage in patients with malignant hilar biliary obstruction: Propensity score‐matched multicenter comparative study. Dig Endosc Published online: 27 Oct 2023; DOI: 10.1111/den.14712
Leung JW, Liu Y, Chan RC et al. Early attachment of anaerobic bacteria may play an important role in biliary stent blockage. Gastrointest Endosc 2000; 52: 725–729.
Leung JW, Liu YL, Desta T, Libby E, Inciardi JF, Lam K. Is there a synergistic effect between mixed bacterial infection in biofilm formation on biliary stents? Gastrointest Endosc 1998; 48: 250–257.
Maillot N, Aucher P, Robert S et al. Polyethylene stent blockage: A porcine model. Gastrointest Endosc 2000; 51: 12–18.
Speer AG, Cotton PB, Rode J et al. Biliary stent blockage with bacterial biofilm. A light and electron microscopy study. Ann Intern Med 1988; 108: 546–553.
Liu Q, Khay G, Cotton PB. Feasibility of stent placement above the sphincter of Oddi (“inside‐stent”) for patients with malignant biliary obstruction. Endoscopy 1998; 30: 687–690.
Ishiwatari H, Hayashi T, Ono M, Sato T, Kato J. Newly designed plastic stent for endoscopic placement above the sphincter of Oddi in patients with malignant hilar biliary obstruction. Dig Endosc 2013; 25 (Suppl 2): 94–99.
Inatomi O, Bamba S, Shioya M et al. Threaded biliary inside stents are a safe and effective therapeutic option in cases of malignant hilar obstruction. BMC Gastroenterol 2013; 13: 31.
Kubota K, Hasegawa S, Iwasaki A et al. Stent placement above the sphincter of Oddi permits implementation of neoadjuvant chemotherapy in patients with initially unresectable Klatskin tumor. Endosc Int Open 2016; 4: E427–E433.
Kanno Y, Koshita S, Ogawa T et al. Inside plastic stents versus metal stents for treating unresectable malignant perihilar biliary obstructions: A retrospective comparative study. Clin Endosc 2020; 53: 735–742.
Kogure H, Kato H, Kawakubo K et al. A prospective multicenter study of “inside stents” for biliary stricture: Multicenter evolving inside stent registry (MEISteR). J Clin Med 2021; 10: 2936.
Kobayashi N, Watanabe S, Hosono K et al. Endoscopic inside stent placement is suitable as a bridging treatment for preoperative biliary tract cancer. BMC Gastroenterol 2015; 15: 8.
Takahashi Y, Sasahira N, Sasaki T et al. The role of stent placement above the papilla (inside‐stent) as a bridging therapy for perihilar biliary malignancy: An initial experience. Surg Today 2021; 51: 1795–1804.
Pedersen FM, Lassen AT, Schaffalitzky de Muckadell OB. Randomized trial of stent placed above and across the sphincter of Oddi in malignant bile duct obstruction. Gastrointest Endosc 1998; 48: 574–579.
Uchida N, Tsutsui K, Ezaki T et al. Estimation of the stent placement above the intact sphincter of Oddi against malignant bile duct obstruction. J Gastroenterol 2005; 40: 291–296.
Kanno Y, Ito K, Nakahara K et al. Suprapapillary placement of plastic versus metal stents for malignant biliary hilar obstructions: A multicenter, randomized trial. Gastrointest Endosc 2023; 98: 211–221.e3.
Ishiwatari H, Kawabata T, Kawashima H et al. Clinical outcomes of inside stents and conventional plastic stents as bridge‐to‐surgery options for malignant hilar biliary obstruction. Dig Dis Sci 2023; 68: 1139–1147.
Ishiwatari H, Satoh T, Sato J et al. Endoscopic ultrasound‐guided rendezvous for access to the right posterior bile duct in a surgical candidate. Endoscopy 2020; 52: E156–E157.